Concord Medical Services Holdings (CCM) Research & Development (2016 - 2017)
Historic Research & Development for Concord Medical Services Holdings (CCM) over the last 6 years, with Q2 2017 value amounting to $29.0 million.
- Concord Medical Services Holdings' Research & Development rose 5101.95% to $29.0 million in Q2 2017 from the same period last year, while for Jun 2017 it was $87.1 million, marking a year-over-year increase of 686.46%. This contributed to the annual value of $92.3 million for FY2015, which is 566.08% down from last year.
- Per Concord Medical Services Holdings' latest filing, its Research & Development stood at $29.0 million for Q2 2017, which was up 5101.95% from $19.2 million recorded in Q2 2016.
- In the past 5 years, Concord Medical Services Holdings' Research & Development ranged from a high of $29.0 million in Q2 2017 and a low of $18.0 million during Q1 2013
- For the 5-year period, Concord Medical Services Holdings' Research & Development averaged around $23.4 million, with its median value being $23.4 million (2015).
- As far as peak fluctuations go, Concord Medical Services Holdings' Research & Development crashed by 2851.91% in 2016, and later skyrocketed by 5101.95% in 2017.
- Quarter analysis of 5 years shows Concord Medical Services Holdings' Research & Development stood at $27.9 million in 2013, then fell by 7.33% to $25.8 million in 2014, then dropped by 22.07% to $20.1 million in 2015, then decreased by 4.72% to $19.2 million in 2016, then surged by 51.02% to $29.0 million in 2017.
- Its last three reported values are $29.0 million in Q2 2017, $19.2 million for Q2 2016, and $18.9 million during Q1 2016.